PrediMed

PrediMed is a healthcare startup based in Israel that is revolutionizing pediatric MRI scans with AI-based tools. The company's AI-based clinical decision support system is designed to reduce the use of sedation and general anesthesia in children undergoing MRI scans, addressing the challenges and risks associated with the current methods.

Founded in 2020 by a diverse team of researchers, engineers, and doctors, all graduates of the Biodesign-Stanford program, PrediMed is currently conducting a clinical trial and has established future collaborations with leading clinical institutions worldwide.

The prevalence of sedating children for MRI scans with general anesthesia not only causes anxiety among parents and children but also entails significant risks and costs. PrediMed's system aims to customize the MRI scan experience for each child, increasing the success rate of undergoing a sedation-free MRI scan by learning the individual needs of the child and matching them with local aids and point-solutions at the MRI institute.

With its mission of creating a world of personal, effective, and healthier systems, PrediMed is poised to make a significant impact in the healthcare industry by introducing innovative solutions that prioritize patient comfort and safety.